The plasma levels of activated thrombin activatable fibrinolysis inhibitor and thrombomodulin in Behcet Disease and their association with thrombosis


DÖNMEZ A. , AKSU K. , AYDIN H., KESER G. , CAGIRGAN S., DOGANAVSARGIL E., ...More

THROMBOSIS RESEARCH, vol.126, no.3, pp.207-210, 2010 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 126 Issue: 3
  • Publication Date: 2010
  • Doi Number: 10.1016/j.thromres.2010.05.019
  • Title of Journal : THROMBOSIS RESEARCH
  • Page Numbers: pp.207-210

Abstract

Objective: To investigate the plasma levels of activated thrombin activatable fibrinolysis inhibitor (aTAFI) and thrombomodulin (TM) in Behcet disease (BD) and their relationship with thrombosis.